aDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan

bDepartment of Thoracic Surgery, the First Affiliated Hospital of Yangtze University, Jingzhou

cDepartment of Oncology, the First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China

Received 14 April 2022 Revised form accepted 14 April 2022

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.anti-cancerdrugs.com.

Correspondence to Qing Geng, PhD, Department of Thoracic Surgery, Renmin Hospital of Wuhan University, No. 238, Jiefang Rd, Wuhan, 430060 Hubei, China, Tel: +86 27 88041911; e-mail: [email protected]